Literature DB >> 23673335

Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.

Thomas Burmeister1, Mara Molkentin, Stefan Schwartz, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel, Richard Reinhardt.   

Abstract

The chromosomal translocation t(8;14)(q24;q32) with juxtaposition of MYC to enhancer elements in the immunoglobulin heavy chain (IGH) gene locus is the genetic hallmark of the majority of Burkitt lymphoma and a subset of Diffuse large B-cell lymphoma patients. Around 3% of adult B-lineage acute lymphoblastic leukemia (ALL) patients show this aberration. Flow cytometry mostly reveals a "mature B-ALL" or "Burkitt-type" ALL immunophenotype. Using long-distance PCR for t(8;14)/MYC-IGH fusion, we investigated bone marrow, peripheral blood and a few other samples with suspected Burkitt-ALL or mature B-ALL and identified 133 MYC-IGH-positive cases. The location of the chromosomal breaks in the IGH joining and the 8 different switch regions was determined using a set of long-distance PCRs. The chromosomal breakpoints with the adjacent MYC regions on 8q24 were characterized by direct sequencing in 49 cases. The distribution of chromosomal breaks among the IGH joining and switch regions was the following: JH 23.3%, M 21.8%, G1 15.0%, G2 7.5%, G3 3.8%, G4 4.5%, A1 12.8%, A2 3.8%, E 7.5%. Two breakpoint clusters near MYC were delineated. There was no clear correlation between the degree of somatic hypermutation and the chromosomal break locations. Epstein Barr virus was detected in 5 cases (4%). This detailed and extensive molecular analysis illustrates the molecular complexity of the MYC-IGH translocations and the detected distribution of breakpoints provides additional evidence that this translocation results from failed switch and VDJ recombinations. This study may serve as a model for the analysis of other IGH translocations in B-cell lymphoma.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Burkitt lymphoma; Isotype switching; MYC; VDJ recombination

Mesh:

Year:  2013        PMID: 23673335      PMCID: PMC5528421          DOI: 10.1016/j.molonc.2013.04.006

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  37 in total

Review 1.  Mechanisms of chromosomal translocations in B cell lymphomas.

Authors:  R Küppers; R Dalla-Favera
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

Review 2.  Burkitt lymphoma: the role of Epstein-Barr virus revisited.

Authors:  Sebastian Grömminger; Josef Mautner; Georg W Bornkamm
Journal:  Br J Haematol       Date:  2012-03       Impact factor: 6.998

Review 3.  VH replacement in mice and humans.

Authors:  Zhixin Zhang
Journal:  Trends Immunol       Date:  2007-01-26       Impact factor: 16.687

Review 4.  Myc translocations in B cell and plasma cell neoplasms.

Authors:  Siegfried Janz
Journal:  DNA Repair (Amst)       Date:  2006-07-11

5.  Reference values of serum IgA subclasses in caucasian adults by immunonephelometry.

Authors:  M Berth; J Delanghe; M Langlois; M De Buyzere
Journal:  Clin Chem       Date:  1999-02       Impact factor: 8.327

6.  Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromes.

Authors:  M-A Alyanakian; E Bernatowska; J-M Scherrmann; P Aucouturier; J-L Poplavsky
Journal:  Vox Sang       Date:  2003-04       Impact factor: 2.144

7.  A region of the 20 bp repeats lies 3' of human Ig Calpha1 and Calpha2 genes.

Authors:  C Chen; B K Birshtein
Journal:  Int Immunol       Date:  1996-01       Impact factor: 4.823

8.  AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation.

Authors:  Michelle L Duquette; Phuong Pham; Myron F Goodman; Nancy Maizels
Journal:  Oncogene       Date:  2005-09-01       Impact factor: 9.867

9.  Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.

Authors:  B Shiramizu; F Barriga; J Neequaye; A Jafri; R Dalla-Favera; A Neri; M Guttierez; P Levine; I Magrath
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

10.  Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.

Authors:  B Smith-Sørensen; E M Hijmans; R L Beijersbergen; R Bernards
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

View more
  7 in total

1.  High-throughput sequencing reveals novel features of immunoglobulin gene rearrangements in Burkitt lymphoma.

Authors:  Katharine A Lombardo; David G Coffey; Alicia J Morales; Christopher S Carlson; Andrea M H Towlerton; Sarah E Gerdts; Francis K Nkrumah; Janet Neequaye; Robert J Biggar; Jackson Orem; Corey Casper; Sam M Mbulaiteye; Kishor G Bhatia; Edus H Warren
Journal:  Blood Adv       Date:  2017-07-03

2.  Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation.

Authors:  Ekaterina Mikhailovna Stasevich; Aksinya Nicolaevna Uvarova; Matvey Mikhailovich Murashko; Elmira Ramilevna Khabusheva; Saveliy Andreevich Sheetikov; Vladimir Sergeyevich Prassolov; Dmitriy Vladimirovich Kuprash; Denis Eriksonovich Demin; Anton Markovich Schwartz
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

3.  FANCJ is essential to maintain microsatellite structure genome-wide during replication stress.

Authors:  Joanna Barthelemy; Helmut Hanenberg; Michael Leffak
Journal:  Nucleic Acids Res       Date:  2016-05-13       Impact factor: 16.971

4.  Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.

Authors:  Cristina López; Kortine Kleinheinz; Sietse M Aukema; Marius Rohde; Stephan H Bernhart; Daniel Hübschmann; Rabea Wagener; Umut H Toprak; Francesco Raimondi; Markus Kreuz; Sebastian M Waszak; Zhiqin Huang; Lina Sieverling; Nagarajan Paramasivam; Julian Seufert; Stephanie Sungalee; Robert B Russell; Julia Bausinger; Helene Kretzmer; Ole Ammerpohl; Anke K Bergmann; Hans Binder; Arndt Borkhardt; Benedikt Brors; Alexander Claviez; Gero Doose; Lars Feuerbach; Andrea Haake; Martin-Leo Hansmann; Jessica Hoell; Michael Hummel; Jan O Korbel; Chris Lawerenz; Dido Lenze; Bernhard Radlwimmer; Julia Richter; Philip Rosenstiel; Andreas Rosenwald; Markus B Schilhabel; Harald Stein; Stephan Stilgenbauer; Peter F Stadler; Monika Szczepanowski; Marc A Weniger; Marc Zapatka; Roland Eils; Peter Lichter; Markus Loeffler; Peter Möller; Lorenz Trümper; Wolfram Klapper; Steve Hoffmann; Ralf Küppers; Birgit Burkhardt; Matthias Schlesner; Reiner Siebert
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

Review 5.  Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.

Authors:  Renata Woroniecka; Grzegorz Rymkiewicz; Lukasz M Szafron; Katarzyna Blachnio; Laura A Szafron; Zbigniew Bystydzienski; Barbara Pienkowska-Grela; Klaudia Borkowska; Jolanta Rygier; Aleksandra Kotyl; Natalia Malawska; Katarzyna Wojtkowska; Joanna Parada; Anita Borysiuk; Victor Murcia Pienkowski; Malgorzata Rydzanicz; Beata Grygalewicz
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.240

6.  t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.

Authors:  Hitoshi Ohno; Kayo Takeoka; Chiyuki Kishimori; Miho Nakagawa; Katsuhiro Fukutsuka; Fumiyo Maekawa; Masahiko Hayashida; Takashi Akasaka; Shinji Sumiyoshi
Journal:  J Clin Exp Hematop       Date:  2021-10-26

7.  Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human.

Authors:  Anthony B Eason; Sang-Hoon Sin; Carolina Lin; Blossom Damania; Steven Park; Yuri Fedoriw; Carlos E Bacchi; Dirk P Dittmer
Journal:  Oncotarget       Date:  2016-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.